Clinical Trial Update: A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II study of gimatecan (ST1481) in locally advanced or metastatic pancreatic cancer is ongoing with an unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• gimatecan (ST1481) (gimatecan)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN